FDA inspection

Hikma Pharmaceuticals LLC: FDA inspection ending Sep 5, 2019

FDA inspection 1101407 · Voluntary Action Indicated (VAI) · Amman

Key facts

Inspection ID 1101407
Firm Hikma Pharmaceuticals LLC
FEI number 3002806351
Address Baywader Wadi El-Seer, Industrial Airport Road
City Amman
Country Jordan
Fiscal year 2019
Inspection end date Sep 5, 2019
Classification Voluntary Action Indicated (VAI)
Project area Drug Quality Assurance
Product type Drugs

At a glance

  • 1–9 Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections